APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lung Cancer Diagnostic And Screening

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lung Cancer Diagnostic And Screening Industry Growth and Trends Forecast to 2032

5 March 2026114 pages

Choose your research edition.

Industry ResearchLung Cancer Diagnostic And Screening Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Lung Cancer Diagnostic And Screening Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Lung Cancer Diagnostic And Screening Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lung Cancer Diagnostic And Screening Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Lung Cancer Diagnostic And Screening Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

According to APO Research, the global Lung Cancer Diagnostic And Screening market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lung Cancer Diagnostic And Screening is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lung Cancer Diagnostic And Screening is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lung Cancer Diagnostic And Screening is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Lung Cancer Diagnostic And Screening market include Pfizer, F.Hoffmann-La Roche AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific, AstraZeneca Plc, Abbott Laboratories, Medtronic Plc, Danaher Corporation and Siemens Healthcare GmbH, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lung Cancer Diagnostic And Screening market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lung Cancer Diagnostic And Screening market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lung Cancer Diagnostic And Screening market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lung Cancer Diagnostic And Screening.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Lung Cancer Diagnostic And Screening market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lung Cancer Diagnostic And Screening Market by Company

Pfizer

F.Hoffmann-La Roche AG

Bristol-Myers Squibb Company

Thermo Fisher Scientific

AstraZeneca Plc

Abbott Laboratories

Medtronic Plc

Danaher Corporation

Siemens Healthcare GmbH

FUJIFILM Corporation

KoninklijikePhilips N.V.

GE Healthcare Bio Sciences AB

Quest Diagnostics lIncorporated

Agilent Technologies lnc

Qiagen Inc.

Myriad Genetic Laboratories Inc.

NeoGenomics Laboratories Inc

Canon MedicalSystems Corporation

Eon Health Inc

Lung Cancer Diagnostic And Screening Segment by Type

Instrument

Consumables and Accessories

Lung Cancer Diagnostic And Screening Segment by Application

Hospital

Independent Diagnostic Laboratory

Lung Cancer Diagnostic And Screening Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lung Cancer Diagnostic And Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lung Cancer Diagnostic And Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lung Cancer Diagnostic And Screening.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Lung Cancer Diagnostic And Screening companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Lung Cancer Diagnostic And Screening Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Lung Cancer Diagnostic And Screening Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Lung Cancer Diagnostic And Screening Market Share by Region (2021-2026) Table 4. Global Lung Cancer Diagnostic And Screening Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Lung Cancer Diagnostic And Screening Market Share by Region (2027-2032) Table 6. Global Lung Cancer Diagnostic And Screening Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Lung Cancer Diagnostic And Screening Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Lung Cancer Diagnostic And Screening Market Size Share by Type (2021-2026) Table 9. Global Lung Cancer Diagnostic And Screening Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Lung Cancer Diagnostic And Screening Market Size Share Forecasted by Type (2027-2032) Table 11. North America Lung Cancer Diagnostic And Screening Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Lung Cancer Diagnostic And Screening Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Lung Cancer Diagnostic And Screening Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Lung Cancer Diagnostic And Screening Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Lung Cancer Diagnostic And Screening Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Lung Cancer Diagnostic And Screening Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Lung Cancer Diagnostic And Screening Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Lung Cancer Diagnostic And Screening Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Lung Cancer Diagnostic And Screening Market Size Share by Application (2021-2026) Table 24. Global Lung Cancer Diagnostic And Screening Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Lung Cancer Diagnostic And Screening Market Size Share Forecasted by Application (2027-2032) Table 26. North America Lung Cancer Diagnostic And Screening Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Lung Cancer Diagnostic And Screening Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Lung Cancer Diagnostic And Screening Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Lung Cancer Diagnostic And Screening Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Lung Cancer Diagnostic And Screening Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Lung Cancer Diagnostic And Screening Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Lung Cancer Diagnostic And Screening Industry Trends Table 37. Lung Cancer Diagnostic And Screening Industry Drivers Table 38. Lung Cancer Diagnostic And Screening Industry Opportunities and Challenges Table 39. Lung Cancer Diagnostic And Screening Industry Restraints Table 40. Global Lung Cancer Diagnostic And Screening Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Lung Cancer Diagnostic And Screening Revenue Market Share by Company (2021-2026) Table 42. Global Lung Cancer Diagnostic And Screening Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Lung Cancer Diagnostic And Screening Key Company Headquarters & Area Served Table 44. Global Lung Cancer Diagnostic And Screening Company, Product Type & Application Table 45. Global Lung Cancer Diagnostic And Screening Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Lung Cancer Diagnostic And Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Pfizer Company Information Table 49. Pfizer Business Overview Table 50. Pfizer Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Pfizer Lung Cancer Diagnostic And Screening Product Portfolio Table 52. Pfizer Recent Development Table 53. F.Hoffmann-La Roche AG Company Information Table 54. F.Hoffmann-La Roche AG Business Overview Table 55. F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Portfolio Table 57. F.Hoffmann-La Roche AG Recent Development Table 58. Bristol-Myers Squibb Company Company Information Table 59. Bristol-Myers Squibb Company Business Overview Table 60. Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Portfolio Table 62. Bristol-Myers Squibb Company Recent Development Table 63. Thermo Fisher Scientific Company Information Table 64. Thermo Fisher Scientific Business Overview Table 65. Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Portfolio Table 67. Thermo Fisher Scientific Recent Development Table 68. AstraZeneca Plc Company Information Table 69. AstraZeneca Plc Business Overview Table 70. AstraZeneca Plc Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Portfolio Table 72. AstraZeneca Plc Recent Development Table 73. Abbott Laboratories Company Information Table 74. Abbott Laboratories Business Overview Table 75. Abbott Laboratories Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Abbott Laboratories Lung Cancer Diagnostic And Screening Product Portfolio Table 77. Abbott Laboratories Recent Development Table 78. Medtronic Plc Company Information Table 79. Medtronic Plc Business Overview Table 80. Medtronic Plc Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Medtronic Plc Lung Cancer Diagnostic And Screening Product Portfolio Table 82. Medtronic Plc Recent Development Table 83. Danaher Corporation Company Information Table 84. Danaher Corporation Business Overview Table 85. Danaher Corporation Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Danaher Corporation Lung Cancer Diagnostic And Screening Product Portfolio Table 87. Danaher Corporation Recent Development Table 88. Siemens Healthcare GmbH Company Information Table 89. Siemens Healthcare GmbH Business Overview Table 90. Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Portfolio Table 92. Siemens Healthcare GmbH Recent Development Table 93. FUJIFILM Corporation Company Information Table 94. FUJIFILM Corporation Business Overview Table 95. FUJIFILM Corporation Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Portfolio Table 97. FUJIFILM Corporation Recent Development Table 98. KoninklijikePhilips N.V. Company Information Table 99. KoninklijikePhilips N.V. Business Overview Table 100. KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Portfolio Table 102. KoninklijikePhilips N.V. Recent Development Table 103. GE Healthcare Bio Sciences AB Company Information Table 104. GE Healthcare Bio Sciences AB Business Overview Table 105. GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Portfolio Table 107. GE Healthcare Bio Sciences AB Recent Development Table 108. Quest Diagnostics lIncorporated Company Information Table 109. Quest Diagnostics lIncorporated Business Overview Table 110. Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Portfolio Table 112. Quest Diagnostics lIncorporated Recent Development Table 113. Agilent Technologies lnc Company Information Table 114. Agilent Technologies lnc Business Overview Table 115. Agilent Technologies lnc Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Portfolio Table 117. Agilent Technologies lnc Recent Development Table 118. Qiagen Inc. Company Information Table 119. Qiagen Inc. Business Overview Table 120. Qiagen Inc. Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Qiagen Inc. Lung Cancer Diagnostic And Screening Product Portfolio Table 122. Qiagen Inc. Recent Development Table 123. Myriad Genetic Laboratories Inc. Company Information Table 124. Myriad Genetic Laboratories Inc. Business Overview Table 125. Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Portfolio Table 127. Myriad Genetic Laboratories Inc. Recent Development Table 128. NeoGenomics Laboratories Inc Company Information Table 129. NeoGenomics Laboratories Inc Business Overview Table 130. NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Portfolio Table 132. NeoGenomics Laboratories Inc Recent Development Table 133. Canon MedicalSystems Corporation Company Information Table 134. Canon MedicalSystems Corporation Business Overview Table 135. Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Portfolio Table 137. Canon MedicalSystems Corporation Recent Development Table 138. Eon Health Inc Company Information Table 139. Eon Health Inc Business Overview Table 140. Eon Health Inc Lung Cancer Diagnostic And Screening Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Eon Health Inc Lung Cancer Diagnostic And Screening Product Portfolio Table 142. Eon Health Inc Recent Development Table 143. North America Lung Cancer Diagnostic And Screening Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. North America Lung Cancer Diagnostic And Screening Market Size by Country (2021-2026) & (US$ Million) Table 145. North America Lung Cancer Diagnostic And Screening Market Share by Country (2021-2026) Table 146. North America Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. North America Lung Cancer Diagnostic And Screening Market Share Forecast by Country (2027-2032) Table 148. Europe Lung Cancer Diagnostic And Screening Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Europe Lung Cancer Diagnostic And Screening Market Size by Country (2021-2026) & (US$ Million) Table 150. Europe Lung Cancer Diagnostic And Screening Market Share by Country (2021-2026) Table 151. Europe Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Europe Lung Cancer Diagnostic And Screening Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Lung Cancer Diagnostic And Screening Market Share by Country (2021-2026) Table 156. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Lung Cancer Diagnostic And Screening Market Share Forecast by Country (2027-2032) Table 158. Latin America Lung Cancer Diagnostic And Screening Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Lung Cancer Diagnostic And Screening Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Lung Cancer Diagnostic And Screening Market Share by Country (2021-2026) Table 161. Latin America Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Lung Cancer Diagnostic And Screening Market Share Forecast by Country (2027-2032) Table 163. Middle East & Africa Lung Cancer Diagnostic And Screening Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East & Africa Lung Cancer Diagnostic And Screening Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East & Africa Lung Cancer Diagnostic And Screening Market Share by Country (2021-2026) Table 166. Middle East & Africa Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East & Africa Lung Cancer Diagnostic And Screening Market Share Forecast by Country (2027-2032) Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Lung Cancer Diagnostic And Screening Product Image Figure 3. Global Lung Cancer Diagnostic And Screening Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Lung Cancer Diagnostic And Screening Market Size (2021-2032) & (US$ Million) Figure 5. Global Lung Cancer Diagnostic And Screening Market Share by Region: 2025 VS 2032 Figure 6. Global Lung Cancer Diagnostic And Screening Market Share by Region (2021-2032) Figure 7. North America Lung Cancer Diagnostic And Screening Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Lung Cancer Diagnostic And Screening Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Lung Cancer Diagnostic And Screening Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Lung Cancer Diagnostic And Screening Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Instrument Image Figure 13. Global Instrument Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Consumables and Accessories Image Figure 15. Global Consumables and Accessories Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Lung Cancer Diagnostic And Screening Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Lung Cancer Diagnostic And Screening Market Share by Type 2025 VS 2032 Figure 18. North America Lung Cancer Diagnostic And Screening Market Size Share by Type (2021-2032) Figure 19. Europe Lung Cancer Diagnostic And Screening Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Share by Type (2021-2032) Figure 21. Latin America Lung Cancer Diagnostic And Screening Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Independent Diagnostic Laboratory Image Figure 26. Global Independent Diagnostic Laboratory Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global Lung Cancer Diagnostic And Screening Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Lung Cancer Diagnostic And Screening Market Share by Application 2025 VS 2032 Figure 29. North America Lung Cancer Diagnostic And Screening Market Size Share by Application (2021-2032) Figure 30. Europe Lung Cancer Diagnostic And Screening Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Share by Application (2021-2032) Figure 32. Latin America Lung Cancer Diagnostic And Screening Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 Lung Cancer Diagnostic And Screening Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America Lung Cancer Diagnostic And Screening Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America Lung Cancer Diagnostic And Screening Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America Lung Cancer Diagnostic And Screening Market Share by Country (2021-2032) Figure 39. Europe Lung Cancer Diagnostic And Screening Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe Lung Cancer Diagnostic And Screening Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe Lung Cancer Diagnostic And Screening Market Share by Country (2021-2032) Figure 42. Asia-Pacific Lung Cancer Diagnostic And Screening Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific Lung Cancer Diagnostic And Screening Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific Lung Cancer Diagnostic And Screening Market Share by Country (2021-2032) Figure 45. Latin America Lung Cancer Diagnostic And Screening Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America Lung Cancer Diagnostic And Screening Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America Lung Cancer Diagnostic And Screening Market Share by Country (2021-2032) Figure 48. Middle East & Africa Lung Cancer Diagnostic And Screening Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa Lung Cancer Diagnostic And Screening Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa Lung Cancer Diagnostic And Screening Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • Instrument
  • Consumables and Accessories
Applications
  • Hospital
  • Independent Diagnostic Laboratory
Companies covered
  • Pfizer
  • F.Hoffmann-La Roche AG
  • Bristol-Myers Squibb Company
  • Thermo Fisher Scientific
  • AstraZeneca Plc
  • Abbott Laboratories
  • Medtronic Plc
  • Danaher Corporation
  • Siemens Healthcare GmbH
  • FUJIFILM Corporation
  • KoninklijikePhilips N.V.
  • GE Healthcare Bio Sciences AB
  • Quest Diagnostics lIncorporated
  • Agilent Technologies lnc
  • Qiagen Inc.
  • Myriad Genetic Laboratories Inc.
  • NeoGenomics Laboratories Inc
  • Canon MedicalSystems Corporation
  • Eon Health Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Lung Cancer Diagnostic And Screening Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Lung Cancer Diagnostic And Screening Market Size by Region (2021-2032)
  5. 1.4.1 Global Lung Cancer Diagnostic And Screening Market Size by Region (2021-2026)
  6. 1.4.2 Global Lung Cancer Diagnostic And Screening Market Size by Region (2027-2032)
  7. 1.5 Key Regions Lung Cancer Diagnostic And Screening Market Size (2021-2032)
  8. 1.5.1 North America Lung Cancer Diagnostic And Screening Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Lung Cancer Diagnostic And Screening Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Lung Cancer Diagnostic And Screening Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Lung Cancer Diagnostic And Screening Market Size Growth Rate (2021-2032)
2 Lung Cancer Diagnostic And Screening Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Instrument
  3. 2.1.2 Consumables and Accessories
  4. 2.2 Global Lung Cancer Diagnostic And Screening Market Size by Type
  5. 2.2.1 Global Lung Cancer Diagnostic And Screening Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Lung Cancer Diagnostic And Screening Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Lung Cancer Diagnostic And Screening Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Lung Cancer Diagnostic And Screening Market Size by Regions
  9. 2.3.1 North America Lung Cancer Diagnostic And Screening Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Lung Cancer Diagnostic And Screening Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Lung Cancer Diagnostic And Screening Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Breakdown by Type (2021-2026)
3 Lung Cancer Diagnostic And Screening Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Independent Diagnostic Laboratory
  4. 3.2 Global Lung Cancer Diagnostic And Screening Market Size by Application
  5. 3.2.1 Global Lung Cancer Diagnostic And Screening Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Lung Cancer Diagnostic And Screening Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Lung Cancer Diagnostic And Screening Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Lung Cancer Diagnostic And Screening Market Size by Regions
  9. 3.3.1 North America Lung Cancer Diagnostic And Screening Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Lung Cancer Diagnostic And Screening Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Lung Cancer Diagnostic And Screening Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Lung Cancer Diagnostic And Screening Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Lung Cancer Diagnostic And Screening Industry Trends
  2. 4.2 Lung Cancer Diagnostic And Screening Industry Drivers
  3. 4.3 Lung Cancer Diagnostic And Screening Industry Opportunities and Challenges
  4. 4.4 Lung Cancer Diagnostic And Screening Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Lung Cancer Diagnostic And Screening Revenue (2021-2026)
  2. 5.2 Global Lung Cancer Diagnostic And Screening Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Lung Cancer Diagnostic And Screening Key Company Headquarters & Area Served
  4. 5.4 Global Lung Cancer Diagnostic And Screening Company, Product Type & Application
  5. 5.5 Global Lung Cancer Diagnostic And Screening Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Lung Cancer Diagnostic And Screening Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Lung Cancer Diagnostic And Screening Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Lung Cancer Diagnostic And Screening Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Pfizer Lung Cancer Diagnostic And Screening Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 F.Hoffmann-La Roche AG
  8. 6.2.1 F.Hoffmann-La Roche AG Company Information
  9. 6.2.2 F.Hoffmann-La Roche AG Business Overview
  10. 6.2.3 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 F.Hoffmann-La Roche AG Lung Cancer Diagnostic And Screening Product Portfolio
  12. 6.2.5 F.Hoffmann-La Roche AG Recent Developments
  13. 6.3 Bristol-Myers Squibb Company
  14. 6.3.1 Bristol-Myers Squibb Company Company Information
  15. 6.3.2 Bristol-Myers Squibb Company Business Overview
  16. 6.3.3 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bristol-Myers Squibb Company Lung Cancer Diagnostic And Screening Product Portfolio
  18. 6.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 6.4 Thermo Fisher Scientific
  20. 6.4.1 Thermo Fisher Scientific Company Information
  21. 6.4.2 Thermo Fisher Scientific Business Overview
  22. 6.4.3 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Thermo Fisher Scientific Lung Cancer Diagnostic And Screening Product Portfolio
  24. 6.4.5 Thermo Fisher Scientific Recent Developments
  25. 6.5 AstraZeneca Plc
  26. 6.5.1 AstraZeneca Plc Company Information
  27. 6.5.2 AstraZeneca Plc Business Overview
  28. 6.5.3 AstraZeneca Plc Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 AstraZeneca Plc Lung Cancer Diagnostic And Screening Product Portfolio
  30. 6.5.5 AstraZeneca Plc Recent Developments
  31. 6.6 Abbott Laboratories
  32. 6.6.1 Abbott Laboratories Company Information
  33. 6.6.2 Abbott Laboratories Business Overview
  34. 6.6.3 Abbott Laboratories Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Abbott Laboratories Lung Cancer Diagnostic And Screening Product Portfolio
  36. 6.6.5 Abbott Laboratories Recent Developments
  37. 6.7 Medtronic Plc
  38. 6.7.1 Medtronic Plc Company Information
  39. 6.7.2 Medtronic Plc Business Overview
  40. 6.7.3 Medtronic Plc Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Medtronic Plc Lung Cancer Diagnostic And Screening Product Portfolio
  42. 6.7.5 Medtronic Plc Recent Developments
  43. 6.8 Danaher Corporation
  44. 6.8.1 Danaher Corporation Company Information
  45. 6.8.2 Danaher Corporation Business Overview
  46. 6.8.3 Danaher Corporation Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Danaher Corporation Lung Cancer Diagnostic And Screening Product Portfolio
  48. 6.8.5 Danaher Corporation Recent Developments
  49. 6.9 Siemens Healthcare GmbH
  50. 6.9.1 Siemens Healthcare GmbH Company Information
  51. 6.9.2 Siemens Healthcare GmbH Business Overview
  52. 6.9.3 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Siemens Healthcare GmbH Lung Cancer Diagnostic And Screening Product Portfolio
  54. 6.9.5 Siemens Healthcare GmbH Recent Developments
  55. 6.10 FUJIFILM Corporation
  56. 6.10.1 FUJIFILM Corporation Company Information
  57. 6.10.2 FUJIFILM Corporation Business Overview
  58. 6.10.3 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 FUJIFILM Corporation Lung Cancer Diagnostic And Screening Product Portfolio
  60. 6.10.5 FUJIFILM Corporation Recent Developments
  61. 6.11 KoninklijikePhilips N.V.
  62. 6.11.1 KoninklijikePhilips N.V. Company Information
  63. 6.11.2 KoninklijikePhilips N.V. Business Overview
  64. 6.11.3 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 KoninklijikePhilips N.V. Lung Cancer Diagnostic And Screening Product Portfolio
  66. 6.11.5 KoninklijikePhilips N.V. Recent Developments
  67. 6.12 GE Healthcare Bio Sciences AB
  68. 6.12.1 GE Healthcare Bio Sciences AB Company Information
  69. 6.12.2 GE Healthcare Bio Sciences AB Business Overview
  70. 6.12.3 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 GE Healthcare Bio Sciences AB Lung Cancer Diagnostic And Screening Product Portfolio
  72. 6.12.5 GE Healthcare Bio Sciences AB Recent Developments
  73. 6.13 Quest Diagnostics lIncorporated
  74. 6.13.1 Quest Diagnostics lIncorporated Company Information
  75. 6.13.2 Quest Diagnostics lIncorporated Business Overview
  76. 6.13.3 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Quest Diagnostics lIncorporated Lung Cancer Diagnostic And Screening Product Portfolio
  78. 6.13.5 Quest Diagnostics lIncorporated Recent Developments
  79. 6.14 Agilent Technologies lnc
  80. 6.14.1 Agilent Technologies lnc Company Information
  81. 6.14.2 Agilent Technologies lnc Business Overview
  82. 6.14.3 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Agilent Technologies lnc Lung Cancer Diagnostic And Screening Product Portfolio
  84. 6.14.5 Agilent Technologies lnc Recent Developments
  85. 6.15 Qiagen Inc.
  86. 6.15.1 Qiagen Inc. Company Information
  87. 6.15.2 Qiagen Inc. Business Overview
  88. 6.15.3 Qiagen Inc. Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Qiagen Inc. Lung Cancer Diagnostic And Screening Product Portfolio
  90. 6.15.5 Qiagen Inc. Recent Developments
  91. 6.16 Myriad Genetic Laboratories Inc.
  92. 6.16.1 Myriad Genetic Laboratories Inc. Company Information
  93. 6.16.2 Myriad Genetic Laboratories Inc. Business Overview
  94. 6.16.3 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Myriad Genetic Laboratories Inc. Lung Cancer Diagnostic And Screening Product Portfolio
  96. 6.16.5 Myriad Genetic Laboratories Inc. Recent Developments
  97. 6.17 NeoGenomics Laboratories Inc
  98. 6.17.1 NeoGenomics Laboratories Inc Company Information
  99. 6.17.2 NeoGenomics Laboratories Inc Business Overview
  100. 6.17.3 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 NeoGenomics Laboratories Inc Lung Cancer Diagnostic And Screening Product Portfolio
  102. 6.17.5 NeoGenomics Laboratories Inc Recent Developments
  103. 6.18 Canon MedicalSystems Corporation
  104. 6.18.1 Canon MedicalSystems Corporation Company Information
  105. 6.18.2 Canon MedicalSystems Corporation Business Overview
  106. 6.18.3 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Canon MedicalSystems Corporation Lung Cancer Diagnostic And Screening Product Portfolio
  108. 6.18.5 Canon MedicalSystems Corporation Recent Developments
  109. 6.19 Eon Health Inc
  110. 6.19.1 Eon Health Inc Company Information
  111. 6.19.2 Eon Health Inc Business Overview
  112. 6.19.3 Eon Health Inc Lung Cancer Diagnostic And Screening Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Eon Health Inc Lung Cancer Diagnostic And Screening Product Portfolio
  114. 6.19.5 Eon Health Inc Recent Developments
7 North America
  1. 7.1 North America Lung Cancer Diagnostic And Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Lung Cancer Diagnostic And Screening Market Size by Country (2021-2026)
  3. 7.3 North America Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Lung Cancer Diagnostic And Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Lung Cancer Diagnostic And Screening Market Size by Country (2021-2026)
  3. 8.3 Europe Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Lung Cancer Diagnostic And Screening Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Lung Cancer Diagnostic And Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Lung Cancer Diagnostic And Screening Market Size by Country (2021-2026)
  3. 10.3 South America Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Lung Cancer Diagnostic And Screening Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Lung Cancer Diagnostic And Screening Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Lung Cancer Diagnostic And Screening Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst